DUBLIN, Aug. 12, 2021 /PRNewswire/ -- The "Global Nebulizer System Market, By Product Type (Jet Nebulizer System, Mesh Nebulizer System, Ultrasonic Nebulizer System), By Accessories (Main Apparatus ...

To be effective in treating respiratory illnesses, liquid drugs must be utilized in an aerosol with an effective and defined drop size distribution for inhaled medications. To meet these intense ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. If you’re dealing with a respiratory illness, it can be ...

LANGHORNE, Pa., December 02, 2025--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European ...

- LONHALA MAGNAIR is the first nebulized long-acting muscarinic antagonist (LAMA) available for the treatment of COPD in the U.S. - MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc.

NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, reports that the Israeli Patent Office (ILPO) ...

The first DTC ad campaign for Viatris and Theravance’s COPD nebulizer therapy Yupelri aims to show the freedom of the once-daily treatment. In a newly debuted TV ad, an older woman celebrates her ...

Autoimmune PAP is a rare lung disease characterized by the abnormal build-up of surfactant in the alveoli of the lungs. Surfactant consists of proteins and lipids and is an important physiological ...